Endocrine regulation of neurotransmitter transporters

Epilepsy Research

Volumn 37, Issue 3, 1999, Pages 203-210

  Figlewicz, Dianne P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Dopamine; Glucocorticoids; Insulin; Transporters

Indexed keywords

4 AMINOBUTYRIC ACID; CORTICOSTEROID; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE TRANSPORTER; INSULIN; NEUROTRANSMITTER; PROTEIN KINASE C;

CONFERENCE PAPER; DIET; DIET RESTRICTION; ENERGY BALANCE; EPILEPSY; HUMAN; IN VITRO STUDY; KETOGENESIS; METABOLISM; PRIORITY JOURNAL; SIGNAL PROCESSING;

ANIMALS; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EPILEPSY; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; HYDROCORTISONE; INSULIN; KETONE BODIES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGANIC ANION TRANSPORTERS; SYMPORTERS;

EID: 0032856461     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00072-8     Document Type: Conference Paper

References (55)

1. Arase K., Fisler J.S., Shargill N.S., York D.A., Bray G.A. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. Am. J. Physiol. 255:1988;R974-R981.
2. Attali G., Weizman A., Gil-Ad I., Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 756:1997;153-159.
3. Batchelor M., Schenk J.O. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18:1998;10304-10309.
4. Bosse R., Rivest R., Di Paolo T. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Mol. Brain Res. 46:1997;343-346.
5. Boyd F.T. Jr, Clarke D.W., Muther T.F., Raizada M.K. Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain. J. Biol. Chem. 260:1985;15880-15884.
6. Boyd F.T. Jr, Clarke D.W., Raizada M.K. Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain. Brain Res. 398:1986;1-5.
7. Brann D.W., Hendry L.B., Mahesh V.B. Emerging diversities in the mechanism of action of steroid hormones. J. Steroid. Biochem. Mol. Biol. 52:1995;113-133.
8. Cheatham, B., Kahn, C.R., 1995. Insulin action and the insulin signalling network, Endo. Rev. 16, 117-142.
9. Copeland B.J., Vogelsberg V., Neff N.H., Hadjiconstantinou M. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharm. Exp. Ther. 277:1996;1527-1532.
10. Corey J.L., Davidson N., Lester H.A., Brecha N., Quick M.W. Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J. Biol. Chem. 269:1994;14759-14767.
11. Cushman S.W., Wardzala L.J. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem. 255:1980;4758-4762.
12. During M.J., Ryder K.M., Spencer D.D. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376:1995;174-177.
13. Figlewicz D.P., Bentson K., Ocrant I. The effect of insulin on norepinephrine uptake by PC-12 cells. Brain Res. Bull. 32:1993;425-431.
14. Figlewicz D.P., Szot P., Israel P.A., Payne C., Dorsa D.M. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res. 602:1993;161-164.
15. Figlewicz D.P., Szot P., Chavez M., Woods S.C., Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 644:1994;331-334.
16. Figlewicz D.P., Brot M.D., McCall A.L., Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 736:1996;54-60.
17. Fleckenstein A.E., Pogun S., Carroll F.I., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 B-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenyethyl ester hydrochloride]. J. Pharm. Exp. Ther. 279:1996;200-206.
18. Fumagalli F., Jones S.R., Caron M.G., Seidler F.J., Slotkin T.A. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res. 719:1996;225-228.
19. Gilad G.M., Rabey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 40:1987;2401-2408.
20. Giros G., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
21. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M.C. et al. Cloning and expression of a rat brain GABA transporter. Science. 249:1990;1303-1306.
22. Hoffman B.J. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs. Pharmacopsychiatric. 27:1994;16-22.
23. max. J. Neurochem. 68:1997;225-232.
24. Jaber M., Jones S., Giros B., Caron M.G. The dopamine transporter: a crucial component regulating dopamine transmission. Move. Disorders. 12:1997;629-633.
25. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
26. Kitayama S., Shimada S., Xu H., Markham L., Donovan D.M., Uhl G.R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA. 89:1992;7782-7785.
27. Kitayama S., Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jap. J. Pharm. 72:1996;195-208.
28. Langfort J., Pilis W., Zarzeczny R., Nazar K., Kaciuba-Uscilko H. Effect of low-carbohydrate-ketogenic diet on metabolic and hormonal responses to graded exercise in men. J. Physiol. Pharmacol. 47:1996;361-371.
29. Lee S.H., Son H., Chang M.Y., Kang S.H., Chin J., Lee Y.S. Protein kinase C-mediated regulation of dopamine transporter is not achieved by direct phosphorylation on the transporter. Soc. Neurosci. Abstr. 24:1998;607.
30. Meiergerd S.M., Hooks S.M., Schenk J.O. The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration. J. Neurochem. 63:1994;1277-1281.
31. Orchinik M., Murray T.F., Moore F.L. A corticosteroid receptor in neuronal membranes. Science. 252:1991;1848-1851.
32. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
33. Patterson T., Brot M.D., Zavosh A., Schenk J.O., Szot P., Figlewicz D.P. Fasting decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology. 68:1998;11-20.
34. Patterson T.A., Zavosh A., Schenk J.O., Wilkinson C.W., Figlewicz D.P. Acute corticosterone incubation in vitro inhibits the function of the dopamine transporter in nucleus accumbens but not striatum of the rat brain. Soc. Neurosci. Abstr. 23:1997;693.
35. Povlock S.L., Amara S.G. The structure and function of norepinephrine, dopamine and serotonin transporters. Reith M.E.A. Neurotransmitter Transporters. 1997;1-28 Totowa NJ, Humana.
36. Pristupa Z.B., McConkey F., Liu F., Man H.Y., Lee F.J., Wang Y.T. et al. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse. 30:1998;79-87.
37. Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L.J., Blakely R.D. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17:1997;45-57.
38. Quick M.W., Corey J.L., Davidson N., Lester H.A. Second messengers, trafficking-related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J. Neurosci. 17:1997;2967-2979.
39. Ramamoorthy S., Giovanetti E., Qian Y., Blakely R.D. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273:1998;2458-2466.
40. Roitman M.F., Patterson T.A., Sakai R.R., Bernstein I.L., Figlewicz D.P. Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum. Am. J. Physiol. 276:1999;R1339-R1345.
41. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P. et al. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-578.
42. Shores M.M., Szot P., Veith R.C. Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via alpha 2 receptors. Brain Res. Mol. Brain Res. 27:1994;337-341.
43. Silvia C.P., Jaber M., King G.R., Ellinwood E.H., Caron M.G. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience. 76:1997;737-747.
44. Simon J.R., Bare D.J., Ghetti B., Richter J.A. A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum. Neurosci. Lett. 224:1997;201-205.
45. Szot P., Ashliegh E.A., Kohen R., Petrie E., Dorsa D.M., Veith R. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res. 618:1993;308-312.
46. Szot P., Reigel C.E., White S.S., Veith R.C. Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine, and serotonin. Mol. Brain Res. 43:1996;233-245.
47. Szot P., White S.S., Veith R.C. Effect of pentylenetretrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA. Mol. Brain Res. 44:1997;46-54.
48. Tejani-Butt S.M., Yang J. A time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography. Neuroendocrinology. 59:1994;235-244.
49. Thompson T.L., Moss R.L. Estrogen regulation of dopamine release in the nucleus accumbens: Genomic- and nongenomic-mediated effects. J. Neurochem. 62:1994;1750-1756.
50. Tian Y., Kapatos G., Granneman J.G., Bannon M.J. Dopamine and γ-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation. Neurosci. Lett. 173:1994;143-146.
51. Vaughan R.A., Uhl G.R. Protein kinase C stimulates dopamine transporter serine phosphorylation. Soc. Neurosci. Abstr. 23:1998;1131.
52. Vrindavanam N.S., Arnaud P., Ma J.X., Altman-Hamamdzic S., Parratto N.P., Sallee F.R. The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter. Neurosci. Lett. 216:1996;133-136.
53. A receptors to postsynaptic domains by insulin. Nature. 388:1997;686-690.
54. Yang S.P., Pau K.Y., Spies H.G. Gonadectomy alters tyrosine hydroxylase and norepinephrine transporter mRNA levels in the locus coeruleus in rabbits. J. Neuroendocrinol. 9:1997;763-768.
55. Zhou D., Huether G., Wiltfang J., Hajak G., Ruther E. Serotonin transporters in the rat frontal cortex: lack of circadian rhythmicity but down-regulation by food restriction. J. Neurochem. 67:1996;656-661.